BioFocus and CHDI Foundation Enter new Five-Year Collaboration for Huntington’s Disease Therapeutics
News Apr 30, 2010
BioFocus and CHDI Foundation, Inc., a non-profit virtual biotech pursuing therapies for Huntington’s disease, announced a new five-year collaboration focused on discovering novel drugs for Huntington’s disease. BioFocus will perform the research and is eligible to receive US$41 million (€31 million) in research fees during the five-year collaboration.
BioFocus will apply its full range of integrated drug discovery services for this program. Integrated biology and chemistry capabilities will be supported by BioFocus’ expertise in complex primary neuronal assay development, high-content screening, fragment-based screening, computational chemistry, ADME/PK and protein crystallography. The new agreement continues and expands the collaboration started in August 2005.
“Having collaborated with CHDI since 2005 in therapeutic target discovery, we are eager to continue working together to develop novel therapies for Huntington's disease and meet this urgent medical need,” said Onno van de Stolpe, CEO of Galapagos. “We are confident that the next five years of this long-standing relationship with CHDI will be as productive as the first five.”
“BioFocus has delivered expert technologies and experienced staff to therapeutic target and drug discovery research in the fight against Huntington’s disease,” said Ignacio Munoz-Sanjuan, Vice-President, Biology at CHDI. “This has encouraged us to extend and expand the collaboration, with the ultimate goal of finding disease-modifying treatments for Huntington’s.”
Gene Associated with Schizophrenia Risk May Regulate NeurodevelopmentNews
The gene is involved in the translation of proteins from RNA and in the proliferation and migration of neurons in the brain.READ MORE
Network Diffusion Reveals Genes Related to Autism Spectrum DisorderNews
Using a computational technique that accounts for how genes interact, scientists revealed genes that may be related to autism spectrum disorder, many of which are also implicated in cancer.READ MORE
Gene Involved in Embryo Development Identified Using CRISPR/Cas9News
Researchers have used genome editing technology to reveal the role of a key gene in human embryos in the first few days of development.READ MORE